Talphera (TLPH) Assets Average (2011 - 2026)
Talphera's (TLPH) quarterly Assets Average came in at $29.9 million in Q1 2026, up 80.18% year-on-year from $16.6 million in Q1 2025, and down 0.97% quarter-over-quarter from $30.2 million in Q4 2025.
Talphera (TLPH) Assets Average (2011 - 2026) Analysis & Trends
Talphera's Assets Average history runs 16 years deep, the most recent figure standing at $29.9 million for Q1 2026.
- On a quarterly basis, Assets Average rose 80.18% year-over-year to $29.9 million in Q1 2026; TTM through Mar 2026 was $29.9 million, a 80.18% increase from a year earlier, with the FY2025 full-year figure at $24.0 million, up 24.14% from the prior year.
- Assets Average fell to $29.9 million in Q1 2026 per TLPH's latest filing, from $30.2 million in the prior quarter.
- Across five years, Assets Average topped out at $74.9 million in Q1 2022 and bottomed at $15.8 million in Q2 2025.
- The 5-year median for Assets Average is $24.6 million (2024), against an average of $32.4 million.
- Across the five-year window, Assets Average sank 65.64% in 2023 and soared 80.18% in 2026, its largest moves.
- Year by year, Assets Average stood at $47.9 million in 2022, then tumbled by 54.43% to $21.8 million in 2023, then dropped by 10.09% to $19.6 million in 2024, then jumped by 54.04% to $30.2 million in 2025, then declined by 0.97% to $29.9 million in 2026.
- Per Business Quant, the three latest TLPH Assets Average figures stand at $29.9 million (Q1 2026), $30.2 million (Q4 2025), and $23.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | 29.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.94 Mn |
| Dec 31, 2025 | 30.23 Mn |
| Sep 30, 2025 | 23.63 Mn |
| Jun 30, 2025 | 15.76 Mn |
| Mar 31, 2025 | 16.62 Mn |
| Dec 31, 2024 | 19.63 Mn |
| Sep 30, 2024 | 22.94 Mn |
| Jun 30, 2024 | 26.81 Mn |
| Mar 31, 2024 | 24.58 Mn |
| Dec 31, 2023 | 21.83 Mn |
| Sep 30, 2023 | 20.49 Mn |
| Jun 30, 2023 | 22.01 Mn |
| Mar 31, 2023 | 36.89 Mn |
| Dec 31, 2022 | 47.90 Mn |
| Sep 30, 2022 | 52.22 Mn |
| Jun 30, 2022 | 64.05 Mn |
| Mar 31, 2022 | 74.93 Mn |
| Dec 31, 2021 | 75.08 Mn |
| Sep 30, 2021 | 75.92 Mn |
| Jun 30, 2021 | 83.47 Mn |